$1.160
-0.029 (-2.52%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
MIST 相似圖表分析預測
Alphio's MIST stock price prediction model matches the current Milestone Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.14 (-1.83%). The 1-week path is $1.13 (-2.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Milestone Pharmaceuticals Inc 股票嗎？
Milestone Pharmaceuticals Inc is a good buy right now due to its recent positive developments, including a pivotal Phase 3 trial initiation for etripamil, which could significantly enhance its market position. The stock is currently priced at $1.16, and analysts have set a price target of $3, indicating a potential upside of over 150%. Additionally, the company reported a significant increase in prescriptions for its product, with Q2 2026 revenue reaching $559,000, a notable improvement from previous quarters. However, the main risk is the ongoing net losses, with a reported loss of $28.6 million in Q2 2026, which could impact future performance if not addressed.
MIST 股價於 Friday 收在 $1.16，此前下跌 -2.52%
Milestone Pharmaceuticals Inc (MIST) last closed at $1.16, losing -2.52%. These facts feed the 1-day and 1-week MIST price prediction above.
預測驅動因素
Milestone Pharmaceuticals Inc（MIST）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似圖表形態
近期走勢與 MIST 最接近的股票，依相似度排序。
MIST 季節性分析
Historically the probability of a positive August return for MIST is 0.00%. December offers the highest probability of a positive month at 65.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
MIST 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Aug 2026 | $1.21 | $1.55 | $1.78 | +33.71% |
| Sep 2026 | $1.66 | $1.84 | $1.87 | +58.66% |
| Oct 2026 | $1.73 | $1.91 | $2.16 | +64.47% |
| Nov 2026 | $1.71 | $1.91 | $2.16 | +64.47% |
| Dec 2026 | $1.71 | $1.89 | $2.13 | +62.73% |
2026 年，Milestone Pharmaceuticals Inc（MIST）預計區間為 $1.21 至 $2.16。
Milestone Pharmaceuticals Inc 2026 年月度預測
2026 年 Aug，Milestone Pharmaceuticals Inc 預計均價 $1.55，最低 $1.21，最高 $1.78。
2026 年 Sep，Milestone Pharmaceuticals Inc 預計均價 $1.84，最低 $1.66，最高 $1.87。
2026 年 Oct，Milestone Pharmaceuticals Inc 預計均價 $1.91，最低 $1.73，最高 $2.16。
2026 年 Nov，Milestone Pharmaceuticals Inc 預計均價 $1.91，最低 $1.71，最高 $2.16。
2026 年 Dec，Milestone Pharmaceuticals Inc 預計均價 $1.89，最低 $1.71，最高 $2.13。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。